Pharmaceutical company intelligence

Martin Dow Marker products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Pharmaceutical manufacturer - Martin Dow Group · Karachi · Pakistan

Martin Dow Group pharmaceutical entity manufacturing and marketing medicines in Pakistan with a long-standing industrial presence.

Martin Dow Marker products in Pakistan

Martin Dow Marker Limited has 117 medicine presentations registered in Pakistan under 44 brands, covering 43 generic medicines. Most of its products are in Anti-infectives, Endocrine & metabolic and Cardiovascular. Its brands with the most registered strengths and packs are Empaphage-M (Empagliflozin + Metformin), Glucophage XR (Metformin), Klaribact (Clarithromycin) and Mercefex (Ceftriaxone). 117 products have an official DRAP price on MedInfoBase. See all 44 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.

Official website ↗ Official contact ↗

Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details

Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase

Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio

Latest effective price date27 Jul 2026Newest effective date among published current price records

Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Location intelligence

Company location

Google Maps

Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗

Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view

Rx130public portfolio records represented

REG114unique registrations represented

IDX117indexed MedInfoBase presentations

SRC0additional source-observed presentations

R+13registry-only registrations

VER65registry-verified exact registrations

PKR117current validated price records

G43generic molecules in indexed catalogue

DF8dosage-form groups

TA10therapeutic areas

How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage90%

public portfolio presentations with a validated current price

Official-source coverage100%

products linked back to a source record

Unit-price parse coverage100%

priced packs safely normalized per unit

Comparable-market coverage88%

products with at least one like-for-like comparator

Therapeutic classification100%

products assigned to a broad therapeutic area

Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives37 products · 32%

Endocrine & metabolic31 products · 26%

Cardiovascular16 products · 14%

CNS & mental health10 products · 9%

Gastrointestinal & hepatology6 products · 5%

Hematology & thrombosis5 products · 4%

Respiratory & allergy5 products · 4%

Vitamins, minerals & nutrition3 products · 3%

Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antidiabetic medicines31 products · 26%

Third-generation cephalosporins11 products · 9%

Macrolide antibacterials9 products · 8%

Fluoroquinolone antibacterials6 products · 5%

Aminoglycoside antibacterials6 products · 5%

Angiotensin receptor blockers4 products · 3%

Beta blockers4 products · 3%

Antipsychotics4 products · 3%

Formulation footprint

Dosage forms

Tablet75 products

Injection19 products

Capsule7 products

Suspension7 products

Syrup3 products

Drops2 products

Infusion2 products

Inhalation2 products

How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales

#1 Empaphage-MEmpagliflozin + Metformin 19presentations 10 mg + 1000 mg, 12.5 mg + 1000 mg, 12.5 mg + 500 mg, 12.5 mg + 850 mg · Tablet #2 Glucophage XRMetformin 5presentations 1000 mg, 500 mg, 750 mg · Tablet #3 KlaribactClarithromycin 5presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Drops, Suspension, Tablet #4 MercefexCeftriaxone 5presentations 1 g, 250 mg, 500 mg · Injection #5 RefobacinGentamicin 5presentations 10 mg/mL, 20 mg/mL, 40 mg/2 mL, 5 mg/mL gentamicin sulfate (equiv. 3 mg/mL gentamicin; 0.3%) · Injection, Drops #6 Anglozar-DLosartan + Hydrochlorothiazide 4presentations 100 mg + 100 mg, 100 mg + 12.5 mg, 100 mg + 25 mg, 50 mg + 12.5 mg · Tablet

Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis

🔒

MedInfoBase Pharma Pro

See where Martin Dow Marker Limited is priced against the market

103 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint

Unlock with Pharma Pro

How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,361 products · 117 generics 29shared generics HIGH-Q Pharmaceuticals211 products · 61 generics 29shared generics Martin Dow Limited237 products · 61 generics 26shared generics

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers101Distinct registrations among indexed, published, presentation-validated products only

Verified price observations117

Products with a verified price117

Products with multiple price observations0

Source records with multiple versions117

Latest portfolio source check22 Sep 2026

Latest effective price date27 Jul 2026

Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

114 unique registration(s) · 117 indexed presentation(s) · 13 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Brand	Generic	Strength	Form	Pack	Registration	Source-listed price	Unit price	Price position
Actilyse	Alteplase	50 mg	Powder and solvent for solution for injection/infusion	2's	111183	PKR 304,900.15	PKR 152,450.08/vial/unit	No comparator
Actilyse	Alteplase	50 mg	Powder and solvent for solution for injection/infusion	1's	111183	PKR 155,561.17	PKR 155,561.17/vial/unit	No comparator
Advaxaban	Apixaban	5 mg	Tablet	30's	108929	PKR 3,524.61	PKR 117.49/tablet	🔒 Pharma Pro
Advaxaban	Apixaban	2.5 mg	Tablet	30's	108930	PKR 3,315.53	PKR 110.52/tablet	🔒 Pharma Pro
Advit D	Cholecalciferol	5 mg	Injection	1x1ml	093025	PKR 229.77	PKR 229.77/mL	🔒 Pharma Pro
Anglozar	Losartan	50 mg	Tablet	2x10's	112875	PKR 432.44	PKR 21.62/tablet	🔒 Pharma Pro
Anglozar	Losartan	25 mg	Tablet	2x10's	112876	PKR 237.84	PKR 11.89/tablet	🔒 Pharma Pro
Anglozar	Losartan	100 mg	Tablet	10's	114388	PKR 432.45	PKR 43.25/tablet	🔒 Pharma Pro
Anglozar-D	Losartan + Hydrochlorothiazide	50 mg + 12.5 mg	Tablet	2x10's	112872	PKR 619.58	PKR 30.98/tablet	🔒 Pharma Pro
Anglozar-D	Losartan + Hydrochlorothiazide	100 mg + 12.5 mg	Tablet	10's	112873	PKR 454.36	PKR 45.44/tablet	No comparator
Anglozar-D	Losartan + Hydrochlorothiazide	100 mg + 100 mg	Tablet	30's	112873	PKR 1,253.61	PKR 41.79/tablet	No comparator
Anglozar-D	Losartan + Hydrochlorothiazide	100 mg + 25 mg	Tablet	10's	112874	PKR 464.68	PKR 46.47/tablet	🔒 Pharma Pro
Ardoril Chewable Tablet 100mgRegistry verified	Sildenafil Citrate Eq. to Sildenafil	—	—	—	135167Official source ↗	No indexed price	—	—
Ardoril Chewable Tablet 50mgRegistry verified	Sildenafil Citrate Eq. to Sildenafil	—	—	—	135168Official source ↗	No indexed price	—	—
Arzomic	Azithromycin	250 mg	Tablet	6's	100279	PKR 277.00	PKR 46.17/tablet	🔒 Pharma Pro
Arzomic	Azithromycin	500 mg	Tablet	6's	100280	PKR 507.81	PKR 84.64/tablet	🔒 Pharma Pro
Arzomic	Azithromycin	200 mg/5 mL	Suspension	30 ml	100281	PKR 597.16	PKR 19.91/mL	🔒 Pharma Pro
Arzomic	Azithromycin	200 mg/5 mL	Suspension	15ml	100281	PKR 304.68	PKR 20.31/mL	🔒 Pharma Pro
Bi Haler	Budesonide + Formoterol	200 mcg + 200 mcg	Inhalation capsule	30's	117973	PKR 570.02	PKR 19.00/capsule	No comparator
Bi Haler	Budesonide + Formoterol	400 mcg + 400 mcg	Inhalation capsule	30's	117974	PKR 917.56	PKR 30.59/capsule	No comparator
Buscopan	Hyoscine butylbromide	20 mg/mL	Injection	30x1 ml	001121	PKR 320.88	PKR 10.70/mL	🔒 Pharma Pro
Cefomerc	Cefotaxime	250 mg	Injection	1 vial	027804	PKR 110.89	PKR 110.89/vial/unit	🔒 Pharma Pro
Cefomerc	Cefotaxime	500 mg	Powder for injection	1 vial	027805	PKR 170.61	PKR 170.61/vial/unit	🔒 Pharma Pro
Cefomerc	Cefotaxime	1 g	Powder for injection	1 vial	027806	PKR 300.57	PKR 300.57/vial/unit	🔒 Pharma Pro
Concor	Bisoprolol fumarate	5 mg	Tablet	1x14's	010194	PKR 365.96	PKR 26.14/tablet	🔒 Pharma Pro
Concor	Bisoprolol fumarate	10 mg	Tablet	1x14's	010195	PKR 710.81	PKR 50.77/tablet	🔒 Pharma Pro
Concor	Bisoprolol fumarate	2.5 mg	Tablet	1x14's	028000	PKR 201.51	PKR 14.39/tablet	🔒 Pharma Pro
Depex	Fluoxetine	20 mg	Capsule	1x10's	020245	PKR 285.01	PKR 28.50/capsule	🔒 Pharma Pro
Dolo Neurobion CapsuleRegistry verified	Cyanocobalamin , Diclofenac Sodium , Pyridoxine Hydrochloride, Thiamine Hydrochloride	—	—	—	135226Official source ↗	No indexed price	—	—
Dormicum	Midazolam	5 mg/5 mL	Injection	10's	014929	PKR 1,982.13	PKR 198.21/vial/unit	🔒 Pharma Pro
Empaphage	Empagliflozin	10 mg	Tablet	14's	110219	PKR 918.24	PKR 65.59/tablet	🔒 Pharma Pro
Empaphage	Empagliflozin	25 mg	Tablet	14's	110220	PKR 1,099.05	PKR 78.50/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	12.5 mg + 1000 mg	Tablet	28's	114569	PKR 1,791.97	PKR 64.00/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	12.5 mg + 1000 mg	Tablet	14's	114569	PKR 914.43	PKR 65.32/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	12.5 mg + 850 mg	Tablet	14's	114570	PKR 912.49	PKR 65.18/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	12.5 mg + 500 mg	Tablet	28's	114571	PKR 1,760.91	PKR 62.89/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	12.5 mg + 500 mg	Tablet	14's	114571	PKR 898.90	PKR 64.21/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	5 mg + 1000 mg	Tablet	14's	114572	PKR 772.70	PKR 55.19/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	5 mg + 850 mg	Tablet	14's	114573	PKR 770.76	PKR 55.05/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	5 mg + 500 mg	Tablet	7's	114574	PKR 385.37	PKR 55.05/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	5 mg + 500 mg	Tablet	10's	114574	PKR 549.15	PKR 54.92/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	5 mg + 500 mg	Tablet	14's	114574	PKR 769.14	PKR 54.94/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	5 mg + 500 mg	Tablet	28's	114574	PKR 1,506.17	PKR 53.79/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	5 mg + 500 mg	Tablet	30's	114574	PKR 1,615.35	PKR 53.85/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	25 mg + 1000 mg	Tablet	14's	120371	PKR 883.93	PKR 63.14/tablet	No comparator
Empaphage-M	Empagliflozin + Metformin	12.5 mg + 1000 mg	Tablet	28's	120372	PKR 1,709.32	PKR 61.05/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	12.5 mg + 1000 mg	Tablet	14's	120372	PKR 871.92	PKR 62.28/tablet	🔒 Pharma Pro
Empaphage-M	Empagliflozin + Metformin	10 mg + 1000 mg	Tablet	28's	120373	PKR 1,706.32	PKR 60.94/tablet	No comparator
Empaphage-M	Empagliflozin + Metformin	10 mg + 1000 mg	Tablet	14's	120373	PKR 870.42	PKR 62.17/tablet	No comparator
Empaphage-M	Empagliflozin + Metformin	5 mg + 1000 mg	Tablet	28's	120374	PKR 1,445.20	PKR 51.61/tablet	🔒 Pharma Pro

A to Z

All 44 Martin Dow Marker brands in Pakistan

Actilyse Alteplase · 50 mg infusion
Advaxaban Apixaban · 2.5 mg tablet, 5 mg tablet
Advit D Cholecalciferol · 5 mg injection
Anglozar Losartan · 100 mg tablet, 25 mg tablet, 50 mg tablet
Anglozar-D Losartan + Hydrochlorothiazide · 100 mg + 100 mg tablet, 100 mg + 12.5 mg tablet, 100 mg + 25 mg tablet
Arzomic Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
Bi Haler Budesonide + Formoterol · 200 mcg + 200 mcg inhalation, 400 mcg + 400 mcg inhalation
Buscopan Hyoscine butylbromide · 20 mg/mL injection
Cefomerc Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
Concor Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
Depex Fluoxetine · 20 mg capsule
Dormicum Midazolam · 5 mg/5 mL injection
Empaphage Empagliflozin · 10 mg tablet, 25 mg tablet
Empaphage-M Empagliflozin + Metformin · 10 mg + 1000 mg tablet, 12.5 mg + 1000 mg tablet, 12.5 mg + 500 mg tablet
Exigentin Loratadine · 10 mg tablet, 5 mg/5 mL syrup
Glucophage Metformin · 1 g tablet, 250 mg tablet, 500 mg tablet
Glucophage XR Metformin · 1000 mg tablet, 500 mg tablet, 750 mg tablet
Ibusoft Ibuprofen · 100 mg/5 mL suspension, 200 mg capsule, 400 mg capsule
Klaribact Clarithromycin · 125 mg/5 mL suspension, 125 mg/5 mL drops, 250 mg tablet
Laxocare Lactulose · 3.35 mg/5 mL syrup
Levomerc Levofloxacin · 250 mg tablet, 500 mg tablet
Lodopin Amlodipine · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
Lodoz Bisoprolol + Hydrochlorothiazide · 2.5 mg + 6.25 mg tablet
Lumairia Artemether + Lumefantrine · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet
Mercefex Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
Mercip Ciprofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
Meropenex Meropenem · 1 g injection, 500 mg injection
Merstatin Simvastatin · 10 mg tablet, 20 mg tablet
Nespetro Moxifloxacin · 400 mg tablet
Neurobion Thiamine + Pyridoxine + Cyanocobalamin, Thiamine (Vitamin B1) + Pyridoxine (Vitamin B6) + Cyanocobalamin (Vitamin B12) · 100 mg + 100 mg + 200 mcg tablet
Nidonil Gliclazide · 80 mg tablet
Omelcid Omeprazole · 20 mg capsule
Ovi-f Clomifene citrate · 50 mg tablet
Pailet Clopidogrel · 75 mg tablet
Psyper Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
Ranulcid Ranitidine, Gentamicin · 150 mg tablet, 300 mg tablet, 50 mg/2 mL injection
Refobacin Gentamicin · 10 mg/mL injection, 20 mg/mL injection, 40 mg/2 mL injection
Supramycin Doxycycline · 100 mg capsule
Teril Carbamazepine · 200 mg tablet
Tio Haler DPI Tiotropium · 18 mcg capsule
Tixomer Cefixime · 400 mg capsule
Tixomer Dry Cefixime · 100 mg/5 mL suspension, 200 mg/5 mL suspension
Valium Diazepam · 10 mg/2 mL injection
Vicet Levetiracetam · 250 mg tablet, 500 mg tablet

Questions

Martin Dow Marker: common questions

How many products does Martin Dow Marker have in Pakistan?

Martin Dow Marker Limited has 117 registered medicine presentations in Pakistan, sold under 44 brands and covering 43 generic medicines.

What are the main brands of Martin Dow Marker?

By number of registered strengths and packs, its largest brands are Empaphage-M (Empagliflozin + Metformin), Glucophage XR (Metformin), Klaribact (Clarithromycin), Mercefex (Ceftriaxone) and Refobacin (Gentamicin). This is not a sales ranking.

Which therapy areas does Martin Dow Marker cover?

The most products are in Anti-infectives (37), Endocrine & metabolic (31), Cardiovascular (16), CNS & mental health (10) and Gastrointestinal & hepatology (6).

Where can I see Martin Dow Marker medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record

MedInfoBase. (2026). Martin Dow Marker Limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/martin-dow-marker-limited/

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Martin Dow Marker products and prices in Pakistan

Martin Dow Marker products in Pakistan

What is sourced, and how recent is it?

Company profile

Company location

Portfolio at a glance

How complete is this profile?

Downloadable company intelligence charts

Therapeutic Portfolio Mix

Dosage Form Portfolio

Equivalent Price Position

Closest Portfolio Competitors

Therapeutic areas

Drug classes

Dosage forms

Deepest brand families

Unit-price positioning vs equivalent products

See where Martin Dow Marker Limited is priced against the market

Portfolio overlap

Observed database signals

Medicine portfolio

All 44 Martin Dow Marker brands in Pakistan

Martin Dow Marker: common questions

How many products does Martin Dow Marker have in Pakistan?

What are the main brands of Martin Dow Marker?

Which therapy areas does Martin Dow Marker cover?

Where can I see Martin Dow Marker medicine prices?

Cite this record